Here's a concise summary for Cyient DLM's latest results: **Business Performance:** Cyient DLM's Q2 FY26 revenue dipped 20.2% YoY to ₹310.6 Cr, primarily due to the completion of a large order.

Despite this, EBITDA remained resilient at ₹31.2 Cr (-1.4% YoY). Normalized PAT for Q2 stood at ₹12.6 Cr (-18.7% YoY). Key growth segments included Industrial (up 256% YoY), Med-Tech (up 114% YoY), and Aerospace (up 47% YoY), while Defense revenue saw a 90% decline YoY.

The order backlog increased QoQ to ₹2,291.1 Cr. **Growth Drivers & Strategy:** The company is focusing on strengthening existing client relationships and enhancing its "India for India" business.

Strategic initiatives include boosting Build-to-Specification (B2S) offerings, expanding non-Aerospace & Defense segments like Medical and Industrial, and exploring M&A for global presence in NAM/EMEA and new capabilities. **Recent Developments:** Cyient DLM secured two new global clients in Q2: a Japanese EVOTL company and an EV charging solution provider.

Order intake for H1 surged 130% YoY, with large deals in advanced stages.

Technology capabilities in B2S were also enhanced. **Key Financial Metrics:** For Q2 FY26, YoY: Revenue -20.2%, EBITDA -1.4%, Normalized PAT -18.7%. Order backlog reached ₹2,291.1 Cr. **Management Commentary / Outlook:** Management highlighted the company's operational resilience despite the revenue dip, and a continued focus on high-growth segments like Industrial and Med-Tech.

Strong order intake of ₹497.7 Cr in Q2 drove the expansion of the order backlog.